Navigation Links
NHS set to benefit from UK-led technologies
Date:5/17/2012

Video games, pioneering gene therapies and new medical devices are set to transform treatments on the NHS, with support from the Department of Health and the Wellcome Trust.

The experimental technologies are being developed through the Health Innovation Challenge Fund, which was set up in 2009 to stimulate the delivery of products and interventions with potential clinical application in the NHS within a five-year time frame.

Professor Janet Eyre at Newcastle University has been supported by the Fund to develop a system for therapists to monitor patients' arm rehabilitation and recovery after stroke using video games that can be played at home. The patient's movements are measured as part of the game and information on how well they are performing can be relayed to a therapist in the clinic via the internet. The aim is to enable therapists to continually track their patients' recovery and adjust therapy programmes accordingly.

Professor Eyre explains: "We hope that enabling therapists to monitor their patients' progress remotely will improve compliance with home based therapy programmes, speed up recoveries and free up valuable clinic time. Ultimately, therapists will be able to supervise more patients and patients should regain greater independence."

Following collection and validation of the required data from patients playing the games, the team anticipate that the full package will be available to therapists within two years.

The Fund has also supported the world's first clinical trial for a hereditary type of blindness called choroideraemia, using a gene therapy approach. Researchers are still analysing the data but early results are very promising, with no reported adverse effects.

Professor Robert MacLaren from the University of Oxford is leading the clinical trial at the Oxford Eye Hospital together with Professor Miguel Seabra from Imperial College London. Professor MacLaren, who is also consultant
'/>"/>

Contact: Jen Middleton
j.middleton@wellcome.ac.uk
44-207-611-7262
Wellcome Trust
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Vitamin C supplements may reduce benefit from wide range of anti-cancer drugs
2. 12-month ATLANTA trial data show sustained benefit of Catania Stent
3. Brown scientist finds coastal dead zones may benefit some species
4. Stem cell research to benefit horse owners and trainers
5. Mounting evidence shows health benefits of grape polyphenols
6. Optimal dose of vitamin E maximizes benefits, minimizes risk
7. Rhode Island Hospital simulation center examines benefits and applications of medical simulation
8. Even plants benefit from outsourcing
9. Cytori reports benefit of adipose-derived regenerative cells in spinal disc model
10. Honey adds health benefits, is natural preservative and sweetener in salad dressings
11. Benefits of breastfeeding outweigh risk of infant exposure to environmental chemicals in breastmilk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/8/2015)... 2015  Trovagene, Inc. (NASDAQ: TROV ), ... the launch of a study that aims to ... (PCM) technology for predicting response to treatment in ... of the novel immunotherapy agents Yervoy® (ipilumumab), a ... The 50-patient study will be led by researchers ...
(Date:7/7/2015)... 2015 Research and ... of the "Capacitive Fingerprint Sensors Patent Landscape" ... this date, fingerprint sensing technology is the most ... are well developed. This patent landscape focuses on ... The domain of capacitive fingerprint sensors is closely ...
(Date:7/7/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") a biometric ... revised version of one of its first 30 second commercials will ... New York , Chicago , ... metro areas.    , , , , ... the cards in your wallet and keep your identity secure. ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Worldwide Capacitive Fingerprint Sensors Patent Landscape Market Report 2015-2020 - Main IP Holders include Seiko Epson, AuthenTec, Sony and STMicroelectronics 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3
... care for breast cancer have significantly impaired cardio-pulmonary function ... treatment, according to a study led by scientists at ... in the Journal of Clinical Oncology , also ... a strong predictor of survival among women with advanced ...
... most beautiful arachnids in Europe and some of the world,s ... parts of tropical Africa and Asia with conspicuous colonies dotting ... individuals that participate in dramatic mass attacks on prey (Figure ... social species is fascinating and has been the subject of ...
... fertility is usually performed through the observation of the ... does not guarantee an adequate fertility. In fact, there ... and data suggest that abnormal sperm function may have ... by scientists at the Bellvitge Biomedical Research Institute (IDIBELL) ...
Cached Biology News:Cardio fitness levels of breast cancer patients may affect survival 2Velvet spiders emerge from underground in new cybertaxonomic monograph 2Researchers identify genetic markers to predict male fertility 2
(Date:8/3/2015)... 2015 E-QURE Corp. (OTCQB: EQUR), ... Bio-electrical Signal Therapy device ("BST Device"), a new and ... heal chronic wounds, today announced that the Company has ... distributor specializing in medical devices, for the marketing and ... a 70 years old, sales, marketing and distribution company ...
(Date:8/3/2015)... ... 2015 , ... Sterlitech Corporation introduces the compact, quiet, and ... laboratory equipment. With optimized features, such as PTFE-coated contact surfaces, an oil-free design, ... solution for a broad range of vacuum filtration applications. , Featuring a 1/7 ...
(Date:7/31/2015)... ... July 31, 2015 , ... R-Biopharm is ... of partially hydrolyzed gluten in foods, has been accepted by AOAC International as ... Hydrolyzed Gluten in Fermented Cereal-Based Products by R5 Competitive ELISA,” based on a ...
(Date:7/30/2015)... and Dallas, TX, USA (PRWEB) , ... July ... ... innovative nano and microsystems, has appointed Francois Vieillard as Sales & Marketing Director. ... at executive positions, Francois Vieillard will be responsible for reinforcing Tronics’ business development ...
Breaking Biology Technology:E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3Sterlitech Launches New Line of Vacuum Pumps 2RIDASCREEN® Competitve Gliadin Receives AOAC Official First Action Status 2Tronics appoints Francois Vieillard as Sales and Marketing Director 2
... 5 /PRNewswire-FirstCall/ - AEterna Zentaris Inc.,(NASDAQ: AEZS ... on,endocrine therapy and oncology, will announce its second ... on Tuesday, August 12,2008. The Company will host ... later that same day at 4:30 p.m., Eastern ...
... EPS $0.53; Adjusted EPS $0.48, CORONA, Calif., Aug. ... leading specialty pharmaceutical,company, today reported financial results for its ... Results, Net revenue for the second quarter 2008 ... $0.53 per diluted share. Net income for the,second quarter ...
... expands beyond core business of discovery and safety ... the drug discovery and development community, BOSTON ... of validated ion channel-expressing cell lines and,services for ... its fully validated cell lines available to researchers,through ...
Cached Biology Technology:Watson Pharmaceuticals Reports Second Quarter 2008 Results 2Watson Pharmaceuticals Reports Second Quarter 2008 Results 3Watson Pharmaceuticals Reports Second Quarter 2008 Results 4Watson Pharmaceuticals Reports Second Quarter 2008 Results 5Watson Pharmaceuticals Reports Second Quarter 2008 Results 6Watson Pharmaceuticals Reports Second Quarter 2008 Results 7Watson Pharmaceuticals Reports Second Quarter 2008 Results 8Watson Pharmaceuticals Reports Second Quarter 2008 Results 9Watson Pharmaceuticals Reports Second Quarter 2008 Results 10Watson Pharmaceuticals Reports Second Quarter 2008 Results 11Watson Pharmaceuticals Reports Second Quarter 2008 Results 12Watson Pharmaceuticals Reports Second Quarter 2008 Results 13Watson Pharmaceuticals Reports Second Quarter 2008 Results 14Watson Pharmaceuticals Reports Second Quarter 2008 Results 15Watson Pharmaceuticals Reports Second Quarter 2008 Results 16Watson Pharmaceuticals Reports Second Quarter 2008 Results 17ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 2ChanTest Launches New Business to Provide Validated Ion Channel Expressing Cell Lines to the Research Community 3
prototype Nco I...
Provides continuous mixing action. For use with tubes, vials, and other containers...
Based on Silica membrane matrix beads. The kit is designed for the purification of DNA (20 bp - 100 bp) from TAE/TBE agarose gels. Run time is approximately 45 minutes....
Agarose for baculovirus plaque assays which allow optimal growth of plated insect cells....
Biology Products: